Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Warby Parker (WRBY) and Adaptive Biotechnologies (ADPT)
Warby Parker Analyst Ratings
Telsey Advisory Remains a Buy on Warby Parker (WRBY)
Analysts Offer Insights on Consumer Cyclical Companies: AutoNation (AN) and Victoria's Secret (VSCO)
Morgan Stanley Lifts Price Target on Warby Parker to $14 From $13, Keeps Equalweight Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)
JMP Securities Remains a Hold on Warby Parker (WRBY)
Boot Barn Holdings Analyst Ratings
Analysts Conflicted on These Healthcare Names: Madrigal Pharmaceuticals (MDGL) and Warby Parker (WRBY)
Sprouts Farmers Market Analyst Ratings
Warby Parker Analyst Ratings
Abercrombie & Fitch Analyst Ratings
Gap Analyst Ratings
Morgan Stanley Raises Price Target on Carvana to $75 From $45, Keeps Underweight Rating
Carvana Analyst Ratings
Analysts Offer Insights on Consumer Cyclical Companies: Carvana Co (CVNA), BJ's Restaurants (BJRI) and Floor & Decor Holdings (FND)
Analysts Offer Insights on Consumer Cyclical Companies: Green Brick Partners (GRBK), DraftKings (DKNG) and Carvana Co (CVNA)
Navigating 8 Analyst Ratings For Sprouts Farmers Market
Carvana Analyst Ratings
TD Cowen Maintains Hold on Carvana, Raises Price Target to $110